Insmed appoints Paul Hudson, Utpal Koppikar as independent directors

INSM•2026-10-20

Insmed appointed Paul Hudson and Utpal Koppikar as independent directors, effective immediately.

1. New directors

Insmed appointed Paul Hudson and Utpal Koppikar as independent directors, effective immediately. Hudson was Sanofi CEO from September 2019 through February 2026 and previously led Novartis Pharmaceuticals from 2016 to 2019. Koppikar has been Verily Health CFO since April 2023 and previously served as Atara Biotherapeutics CFO from 2018 to 2023.

Insmed appoints Paul Hudson, Utpal Koppikar as independent directors

1. New directors

Related News

Terrestrial Energy names David Williams chief commercial officer

Fortress provides $175 million in senior secured credit facilities to The RealReal

Ardelyx sets third-quarter 2026 financial results call

Hilton to move stock listing to Nasdaq

RTX raises 2026 adjusted EPS outlook to $7.65-$7.75